We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$64.7B
AUM Growth
+$4.87B
Cap. Flow
+$2.39B
Cap. Flow %
3.69%
Top 10 Hldgs %
21.65%
Holding
1,654
New
229
Increased
593
Reduced
547
Closed
141

Top Buys

Rank Stock Value
1
AON icon
Aon
AON
+$708M
2
ACN icon
Accenture
ACN
+$609M
3
LIN icon
Linde
LIN
+$424M
4
TT icon
Trane Technologies
TT
+$235M
5
BIPC icon
Brookfield Infrastructure
BIPC
+$191M

Sector Composition

Rank Sector Weight
1 Financials 20.32%
2 Technology 17.68%
3 Industrials 13.13%
4 Healthcare 9.75%
5 Energy 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UCB
1626
United Community Banks
UCB
$4.24B
-6,589
Closed -$223K
PVLA
1627
Palvella Therapeutics
PVLA
$1.99B
-171
Closed -$14.2K
GTHX
1628
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-77,450
Closed -$421K
SILK
1629
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-4,190
Closed -$221K
VBIV
1630
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
-420
Closed -$4.93K
DCPH
1631
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-21,433
Closed -$351K
KRTX
1632
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
-1,372
Closed -$270K
CD
1633
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
-62,881
Closed -$501K
PRTK
1634
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-21,970
Closed -$41.1K
NUVA
1635
DELISTED
NuVasive, Inc.
NUVA
-9,785
Closed -$404K
UNVR
1636
DELISTED
Univar Solutions Inc.
UNVR
-194,716
Closed -$6.19M
BRMK
1637
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
-22,961
Closed -$81.7K
PRVB
1638
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-57,141
Closed -$604K
AIMC
1639
DELISTED
Altra Industrial Motion Corp
AIMC
-4,023
Closed -$240K
FCRD
1640
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
-137,803
Closed -$587K
ONEM
1641
DELISTED
1Life Healthcare
ONEM
-11,143
Closed -$186K
SRNE
1642
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-25,219
Closed -$22.3K
LHCG
1643
DELISTED
LHC Group LLC
LHCG
-1,642
Closed -$265K
STOR
1644
DELISTED
STORE Capital Corporation
STOR
-9,246
Closed -$296K
KNBE
1645
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
-20,898
Closed -$518K
SJI
1646
DELISTED
South Jersey Industries, Inc.
SJI
-7,637
Closed -$271K
CIXX
1647
DELISTED
CI Financial Corp.
CIXX
-1,412,515
Closed -$14.1M
SWIR
1648
DELISTED
Sierra Wireless
SWIR
-14,249
Closed -$412K
CTIC
1649
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-91,714
Closed -$551K
EMKR
1650
DELISTED
Emcore Corp
EMKR
-1,543
Closed -$14.9K

Similar funds

Mackenzie Financial's Q1 2023 Portfolio in Review

As of Q1 2023, Mackenzie Financial held 1,654 positions worth $64.7B, up 8.1% from $59.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mackenzie Financial deployed $2.39B of net new capital in Q1 2023, opening 229 new positions and adding to 593 existing holdings. Its largest new stake was Aon: 2,287,054 shares worth $721M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Bombardier Recreational Products, an estimated $131M trimmed.

  • Mackenzie Financial's largest Q1 2023 buy was Aon: 2,287,054 shares worth $721M.
  • Mackenzie Financial added most to Brookfield Infrastructure in Q1 2023, an estimated $191M increase.
  • Mackenzie Financial's biggest Q1 2023 reduction was Bombardier Recreational Products, cutting an estimated $131M.
  • Mackenzie Financial fully exited Signature Bank in Q1 2023, selling an estimated $55.3M.
  • Mackenzie Financial's ten largest holdings make up 22% of its $64.7B portfolio in Q1 2023.
  • Mackenzie Financial opened 229 new positions and closed 141 in Q1 2023.
  • Mackenzie Financial's portfolio value rose 8.1% quarter-over-quarter to $64.7B.

Based on Mackenzie Financial's 13F filing for Q1 2023, filed 24 Apr 2023.